Skip to content
BETA
Sign in Start

Menu

Account

Language

Health

Acne Treatment Leads to Rare Cancer Diagnosis in 37-Year-Old Woman

Khaosod Online Thailand One source

A 37-year-old woman discovered a rare uterine cancer after starting oral contraceptives to treat acne, highlighting the potential role of hormones in tumor growth.

A 37-year-old woman named Claudia Pereira has shared her medical experience after a routine decision to treat acne with oral contraceptives led to the discovery of a rare form of uterine cancer. According to reports from Khaosod Online, Pereira began taking birth control pills, but soon experienced persistent vaginal bleeding. While initial medical advice suggested her body was simply adjusting to the medication, the bleeding continued for months, eventually leading to anemia and abnormal discharge. After six months of symptoms, further medical examinations, including an ultrasound and MRI, revealed a 7-centimeter mass. Although doctors initially suspected a benign fibroid, a biopsy confirmed a diagnosis of uterine leiomyosarcoma, a rare cancer originating from smooth muscle cells. Dr. Gina D'Amato, a soft tissue sarcoma specialist, explained that this specific type of cancer can possess estrogen or progesterone receptors, which may cause hormones to accelerate tumor growth. Pereira’s tumor was found to have these receptors. Currently, the patient reports that her condition is in remission. This case serves as a reminder for residents and travelers alike to seek second opinions if symptoms persist after starting new medications. While this specific cancer is rare, the incident underscores the importance of monitoring unusual physical changes. Further research is required to fully understand the long-term implications of hormonal treatments on pre-existing, undiagnosed conditions.